Research

Prevalence, clinical characteristics and outcomes of Guillain‐Barré syndrome spectrum associated with COVID‐19: a systematic review and meta‐analysis

Neuro‐COVID frequency and short‐term outcome in the northern Portuguese population

Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amidst the COVID-19 Pandemic: A Cross-Sectional Study

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

High-dimensional characterization of post-acute sequalae of COVID-19

For May 2021, we have selected: Rentsch CT et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ 202;372:n311. doi: 10.1136/bmj.n311.

For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

Impact of the COVID‐19 pandemic on stroke teleconsultations in Germany in the first half of 2020

Impact of the COVID‐19 pandemic and a national lockdown on hospitalisation for stroke and related 30‐day mortality in France: a nationwide observational study

Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis

Acute transverse myelitis with dysautonomia following SARS-CoV-2 infection: a case report and review of literature

Neurological outcome and quality of life three months after COVID-19: a prospective observational cohort study

Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network